logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Coherus Biosciences, Inc.


USPTO Granted Patents = 76



Trademarks = 10

Forward Citations = 754

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Mark Cornell Manning (61 out of 84 patents)

silverMedal Robert W Payne (35 out of 39 patents)

bronzeMedal Brian P Murphy (20 out of 128 patents)

4.  Douglas Farrar (6 out of 6 patents)

5.  Tsutomu Arakawa (5 out of 20 patents)

6.  Jun Liu (5 out of 46 patents)

7.  Ela Puchacz (4 out of 4 patents)

8.  James Russell Grove (4 out of 4 patents)

9.  Christos Mantzoros (3 out of 3 patents)

10.  Isaias Prado (3 out of 3 patents)

11.  John Ogez (2 out of 2 patents)

12.  Wenchang Ji (2 out of 2 patents)

13.  Patrick Daniel Begley (2 out of 2 patents)

14.  Elzbieta Wiktoria Puchacz (1 out of 2 patents)

15.  Ryan Erik Holcomb (1 out of 15 patents)


Core Competencies:
Sterile Injection Devices
Aqueous Formulations
Recombinant Proteins
Protein Compositions
Etanercept Formulations
Adalimumab Stabilization
Nonalcoholic Fatty Liver Disease
PPARy Agonist
Protein Aggregates Reduction
High Purity Proteins
Syringe Formulations
Lipodystrophy Treatments

76 patents:

1. 11752225 - Systems and methods for producing sterile injection devices (2023-09-12),
2. 11667702 - Stable aqueous formulations of aflibercept (2023-06-06),
3. 11583584 - Stable protein compositions and methods of their use (2023-02-21),
4. 11576971 - Method of filling a container with no headspace (2023-02-14),
5. 11426446 - Stable aqueous formulations of aflibercept (2022-08-30),
6. 11400072 - Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy (2022-08-02),
7. 11396540 - Methods for making recombinant proteins (2022-07-26),
8. 11253508 - PPARy agonist for treatment of progressive supranuclear palsy (2022-02-22),
9. 11229702 - High concentration formulations of adalimumab (2022-01-25),
10. 11135267 - Etanercept formulations stabilized with metal ions (2021-10-05),
11. 11129876 - Etanercept formulations stabilized with amino acids (2021-09-28),
12. 11071782 - Method of filling a container with no headspace (2021-07-27),
13. 11001627 - Correctly folded etanercept in high purity and excellent yield (2021-05-11),
14. 11001623 - Method of manufacturing a protein by perfusion in media with a low amino acid concentration (2021-05-11),
15. 11000588 - Etanercept formulations stabilized with sodium chloride (2021-05-11),
Coherus Biosciences, Inc. is a leading biologics platform company focused on delivering high-quality biosimilar therapeutics that can expand patient access to life-changing medicines. The company’s goal is to become a global leader in the development, manufacture, and commercialization of biosimilars, providing patients around the world with safe, effective, and affordable treatments. Coherus aims to advance healthcare through its dedication to science, innovation, and collaboration with healthcare professionals, strategic partners, and patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
76 Patents

#21 in Redwood City, CA

#1,118 in California

#4,684 in US

#9,620 in the World

...
Redwood City, CA, United States of America

Coherus Biosciences, Inc.

Forward Citations = 754

22 inventors:

goldMedal Mark Cornell Manning (61 out of 84 patents)

silverMedal Robert W Payne (35 out of 39 patents)

bronzeMedal Brian P Murphy (20 out of 128 patents)

4.  Douglas Farrar (6 out of 6 patents)

5.  Tsutomu Arakawa (5 out of 20 patents)

Please report any incorrect information to support@idiyas.com
Loading…